𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis of high specific activity R-and S- warfarin-3H

✍ Scribed by C. E. Cook; C. Ray Tallent; Noel H. Ballentine; George F. Taylor; John A. Kepler


Publisher
John Wiley and Sons
Year
1979
Tongue
French
Weight
358 KB
Volume
16
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

4‐Hydroxy‐3‐[3‐oxo‐1‐(3‐bromophenyl)butyl]‐2H‐1‐benzopyran‐2‐one (3′ ‐bromowarfarin) was synthesized and resolved into its enantiomers by formation of the d‐10‐camphorsulfonate diastereoisomers, which were separated by liquid chromatography and hydrolyzed. The pure enantiomers were reduced with tritium gas to yield R‐ and S‐4‐hydroxy‐3‐[3‐oxo‐1‐(phenyl‐3‐^3^H)butyl]‐2H‐l‐ benzopyran‐2‐one (R‐ and S‐warfarin‐3′‐^3^H) of specific activity 31.2 and 24.9 Ci/mmole, respectively. The compounds have been used to develop a stereoselective radioimmunoassay for warfarin enantiomers.


📜 SIMILAR VOLUMES


Synthesis and 3H NMR of 3H-alaproclate o
✍ Stefan Bengtsson; Lars Gawell; Thomas Högberg; Christer Sahlberg 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 French ⚖ 310 KB

The antidepressant alaproclate (IJ i s a selective i n h i b i t o r o f neuronal serotonin reuptake w i t h 1 ow aff i n i t y f o r other receptor sites. (2, 2-( [ 2,5-3H2]-4-chl orophenyl)-2-methyl-2-propyl 2-aminopropanoate) with high specific a c t i v i t y (38 C i / m o l ) was prepared by h

The synthesis of [3H]cadralazine of high
✍ Derek E. Brundish; Peter D. Kane 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 350 KB

The title compound has been prepared by two different approaches. The first involved a five-stage "hot" synthesis.where the tritiation step was selective debromination of a cyclic Fbromo-a-&unsaturated ketone. double bond was protected by formal aromatisation. this intermediate was determined by pro

Synthesis of high specific activity [15,
✍ Ferenc Ötvös; Sándor Hosztafi; Csaba Simon; Géza Tóth 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 225 KB

Tritium labelling of buprenorphine, a mixed agonist-antagonist opioid ligand, was performed with a specific activity of 2.35 TBq/mmol (63.6 Ci/mrnol) starting with 15,16-didehydrobuprenorphine. Labels at positions 15 and 16 of the morphine skeleton proved to be sufficiently stable under strong acidi